Sunesis to Present at Cowen and Company 31st Annual Health Care Conference
01 Marzo 2011 - 1:30PM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSSD), a biopharmaceutical
company focused on the development and commercialization of new
oncology therapeutics for the treatment of solid and hematologic
cancers, today announced that Senior Vice President of Corporate
Development & Finance and Chief Financial Officer, Eric
Bjerkholt, will be presenting at the Cowen and Company 31st Annual
Health Care Conference on Tuesday, March 8th at 10:15 AM Eastern
Time, at the Boston Marriott Copley Place in Boston, Massachusetts.
A live webcast of the presentation will be available on the
Sunesis website at http://ir.sunesis.com. A replay of the webcast
will be archived on the "Calendar of Events" page in the Investors
and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the
development and commercialization of new oncology therapeutics for
the treatment of solid and hematologic cancers. Sunesis has built a
highly experienced cancer drug development organization committed
to advancing its lead product candidate, voreloxin, to improve the
lives of people with cancer. For additional information on Sunesis
Pharmaceuticals, please visit http://www.sunesis.com.
The Sunesis Pharmaceuticals, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8773
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals,
Inc.
CONTACT: Investor and Media Inquiries:
Andrea Rabney
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Grafico Azioni Sunesis Pharmaceuticals, Inc. (MM) (NASDAQ:SNSSD)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Sunesis Pharmaceuticals, Inc. (MM) (NASDAQ:SNSSD)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Sunesis Pharmaceuticals, Inc. (MM) (NASDAQ): 0 articoli recenti
Più Sunesis Pharmaceuticals, Inc. Articoli Notizie